Higher CRP values constitute a biomarker for a severe disease course, are included in a widely-used clinical risk score for mortality of COVID-19 [3], and associate with neutralizing IFN-AABs along with lower lymphocyte counts in severely affected patients [10]. Here, IFNA1 is linked to COVID-19.